Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$0.99 - $2.91 $27,225 - $80,025
-27,500 Reduced 15.09%
154,711 $0
Q3 2022

Nov 03, 2022

BUY
$0.13 - $2.27 $23,687 - $413,618
182,211 New
182,211 $371,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Darrow Company, Inc. Portfolio

Follow Darrow Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darrow Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Darrow Company, Inc. with notifications on news.